Advertisement

Reagents News: Breaking Reagents News, Comments and Articles. - Page: 5

20:43 EDT 23rd May 2013 | BioPortfolio

Reagents News - Page: 5 RSSTwitter

Read the latest Reagents News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Reagents.

Search or Follow Our Reagents - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Reagents - Page: 5 News.
You can also follow our Reagents - Page: 5 news stories on Twitter: @ReagentsBio

Showing "reagents" News Articles 101 to 125 of 769

Wednesday 10th April 2013

Old Friends, And Those Other Guys

I have affection for some reagents, and have taken a dislike to others. That might be seen as odd, because if there's anything that can't return your feelings, it's a chemical reagent. But after some years in the lab, you associate some compounds (an...

Tuesday 9th April 2013

More rumors of Life Tech bids

New rumors of competing bids for Life Technologies Corp. (NASDAQ:LIFE) surfaced on Tuesday, sending the company up an additional $0.86 to $66.19. Shares of the tools and reagents company have gained 20% since the company announced in January that its...

Rockland Immunochemicals Acquires Epi-Plus® Product Line

Rockland Immunochemicals, Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, assay development, and preclinical studies, today announced the acquisition of the Epi-Plus® antibody product line from 21st Century Biochemicals, Inc. Epi-Plus® antibodies are widely regarded as the most well validated...

Affymetrix Announces Preliminary Revenue for First Quarter 2013

Affymetrix, Inc. (Nasdaq: AFFX) today reported that based on preliminary financial data, the Company expects total revenue of approximately $78 million for the first quarter of 2013, including revenue of approximately $19 million from eBioscience. The Company expects to report cash-on-hand of at least $38 million as of March 31, 2013. “Our reven...

Sigma Life Science and the Culture Collections of Public Health England Collaborate to Distribute Cells and Cellular Extracts

ST. LOUIS, April 9, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today that Sigma Life Science, its innovative biological products and services business, has signed an agreement with the Culture Collections of Public Health England, curators for the European Collection of Cell Cultures (ECACC®). In the agreement, the ECACC collection of unique, expertly preserv...

New Molecular Assay Provides Healthcare Facilities with a Simple, Efficient Way to Detect Dangerous Superbug

BALTIMORE, April 9, 2013 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it received FDA clearance to market the BD MAX™ Cdiff Assay in the United States. The assay is performed on the fully-automated BD MAX™ System and is designed to rapidly and accurately detect the tox...

Monday 8th April 2013

Bioserv Corporation Announces Project Management Office

Bioserv Corporation, a provider of pharmaceutical, medical device, medical diagnostic, and biotechnology cGMP contract manufacturing, clinical packaging, and cold chain and distribution services is pleased to announce the formation of its new Project Management Office. The Project Management Office will be integrated under one management system. All aspect...

CML HealthCare Inc. to Install North America's First and World's Largest Fully Automated BD Kiestra™ Microbiology Platform

MISSISSAUGA, Ontario, April 8, 2013 /PRNewswire/ -- CML HealthCare Inc. (TSX: CLC) (the "Company" or "CML"), a leading community-based provider of laboratory and medical imaging services in Ontario and British Columbia, and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an agreement for CML to install two BD Kiestra™ Total La...

Sunday 7th April 2013

CML HealthCare Inc. to Install North America's First and World's Largest Fully Automated BD Kiestra(TM) Microbiology Platform

MISSISSAUGA, ONTARIO -- (Marketwired) -- 04/08/13 -- CML HealthCare Inc. (TSX: CLC) (the "Company" or "CML"), a leading community-based provider of laboratory and medical imaging services in Ontario and British Columbia, and BD (Becton, Dickinson and Company) ("BD"), a leading global medical technology company, today announced an agreement for CML to install two BD Kiestra™ Total Laboratory Aut...

Friday 5th April 2013

[Miraculins] gets exclusive license to high-risk pregnancy biomarker from [Mount Sinai Hospital]

[Mount Sinai Hospital of Toronto]’s [Samuel Lunenfeld Research Institute] (SLRI) has granted [Miraculins Inc.] (diagnostics) a license to methods and reagents to detect hydroxylated hypoxia inducible factor 1 alpha (HIF-1aOH), a preclinical biomark...

Thursday 4th April 2013

EMERALD BIO MAKES IMAGINATION THE ONLY LIMIT TO PROTEIN PURIFICATION

BEDFORD, MA – April 3, 2013 – Emerald Bio, the protein resource, provides biochemists and other scientists new power and freedom to create unlimited types of protein purification methods for drug discovery using its new ProteinMaker™ 2.0 software. The new software is a free, downloadable upgrade for existing users with a service contract. It is installed in all new ProteinMaker...

EMERALD BIO and NANORACKS TEST SPACE’S MICROGRAVITY AS A NEW LAB FOR DRUG DISCOVERY

BEDFORD, MA – April 5, 2013 – The frontier of biomedical research is in a low orbit above the Earth this month. Emerald Bio scientist Cory J. Gerdts, Ph.D. and The Methodist Hospital Research Institute biochemist Carl Carruthers on behalf of NanoRacks LLC are trying to learn if protein crystals grown in microgravity will help researchers on Earth create drugs that better fight diseas...

Azbil BioVigilant (ABV) Announces Partnership with University of Tennessee (UT) Pharmacy College

Azbil BioVigilant, Inc. (www.biovigilant.com), inventors of Instantaneous Microbial Detection™, announced today that the University of Tennessee (UT) Pharmaceutical Sciences Department will utilize Azbil BioVigilant’s IMD-A® 300-series of rapid microbial monitoring systems in their state-of-the-art as

The First Dedicated Breast Cancer Cell Line Transfection Reagent

MADISON, Wis., April 3, 2013 /PRNewswire/ -- Mirus Bio has expanded its transfection expertise with the development of the TransIT-BrCa Transfection Reagent a high performance, low toxicity, DNA transfection reagent specifically formulated for breast cancer cell types. This new reagent offers users: Superior DNA Delivery—Achieve high expression levels in breast cancer cell types inclu...

Tuesday 2nd April 2013

Dako to Offer New Antibody in U.S. to Diagnose Breast Cancer

GLOSTRUP, DENMARK -- (Marketwired) -- 04/03/13 -- Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, recently received clearance from the U.S. Food and Drug Administration to sell FLEX Monoclonal Rabbit Anti-Human Estrogen Receptor alpha, Clone EP1 in the United States. The clone has been available in Europe for some time and has enjoyed widespread acceptance. "...

Saturday 30th March 2013

AMRESCO’s New VisiGlo™ Prime and VisiGlo™ Select HRP Chemiluminescent Substrate Kits Offer Long-lasting, High Sensitivity Detection

Solon, Ohio (PRWEB) March 31, 2013 Chemiluminescent substrates are standard reagents for the detection of horseradish peroxidase (HRP) in Western blotting. Not all substrates perform equally, however. Critical characteristics to consider for chem...

Thursday 28th March 2013

Meridian Bioscience Recognized by Forbes as One of America’s 100 Most Trustworthy Companies

Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that it has been recognized by Forbes as one of America’s 100 Most Trustworthy Companies. The list is selected following a comprehensive evaluation of governance and accounting practices of candidate companies having market capitalization over $250 million. The rankings are based on data from GMI R...

Life Technologies to Invest $18 Million in Facility Expansion and Current Good Manufacturing Practice Compliance Plan

CARLSBAD, Calif., March 28, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announces plans to invest $18 million in a multi-phase plan to expand its facility in Pleasanton, Calif., where it will implement Current Good Manufacturing Practice (cGMP) capabilities for its genetic analysis products. The project, which executes against Life's roadmap to broaden its offering...

Wednesday 27th March 2013

Cytocentrics is Proud to Announce the Appointment of SciPro as Their New Distribution Partner

Rostock, Germany, March 28, 2013 --(PR.com)-- Graeme Daniels, Sales Director at Cytocentrics, said “We are extremely happy to have found a company of SciPro’s calibre to work with to bring our new CytoPatch2 automated patch clamp system to the North American market. There are clear synergies between our two companies, a shared business philosophy and a desire to exceed our customer...

Tuesday 26th March 2013

Source-Omega Stability Pledges to Replace One Percent of Fish Oil in Five Years with Algae Omega-3

Chapel Hill, NC, March 26, 2013 --(PR.com)-- Source-Omega announces successful completion of their 2 year stability data for SOURCE OIL™. In addition, the company pledges to replace 1 percent of the world’s omega-3 oil inputs. Their current capacity is about a fifth of one percent of current global demand for omega-3 oils. Unlike fish oil, algae oil scale-up provides relatively unlim...

Genalyte Announces CE Mark For Maverick(TM) Detection System And Signs On First European Distributors

SAN DIEGO, March 26, 2013 /PRNewswire/ -- Genalyte, Inc. today announced its Maverick™ Detection System that simultaneously analyzes multiple antibodies and other proteins from a single small sample is now CE marked in Europe for research use.  The company also reported its first European distribution agreements for the Maverick Detection System, signing on specialty distributors M...

Monday 25th March 2013

LifeMap Sciences, a Subsidiary of BioTime, Announces Release of LifeMap DiscoveryTM Version 1.1 with Enhanced Therapeutic Discovery and Commercial Utility

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of LifeMap DiscoveryTM version 1.1 (discovery.lifemapsc.com). LifeMap DiscoveryTM is a key component in LifeMap’s integrated database suite, a discovery platform for biomedical and stem cell research, which also includes GeneCards®, the leading huma...

ALPCO Expands Product Offering with Addition of Flow Cytometry Reagents

Salem, NH, March 25, 2013 --(PR.com)-- For over twenty years, ALPCO has been a provider of immunoassay kits and other life science tools to researchers in the academic, pre-clinical and clinical communities. On March 25, 2013, ALPCO will begin offering high quality, affordable flow cytometry reagents to their growing customer base worldwide. In addition to these reagents, ALPCO will also supply s...

Hospitals, Healthcare Providers to Benefit from a New Premier Agreement for Point of Care Coagulation Meters, Reagents, Consumables and Service

The Premier healthcare alliance today announced a new agreement for point of care coagulation meters, reagents, consumables and service has been awarded to International Technidyne Corporation of Edison, N.J. Effective April 1, 2013, the agreement is available to acute care and continuum of care members of Premier. About the Premie...

COFEPRIS leniency opens doors to stem cell therapies

NEW YORK, March 25, 2013 /PRNewswire/ -- Celltex in Houston moved operations to Mexico early this year along with stem cell companies in India and China who have been inquiring about the Mexican market. According to ReHealth, COFEPRIS, which 2 years ago was closed to stem cell treatment has had a complete change of heart when they approached them again just about a month ago. ReHealth's core...


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement